CFTR c.1584+1190C>T

Variant ID: 7-117200899-C-T

NM_000492.3(CFTR):c.1584+1190C>T

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Nicotine Induces Progressive Properties of Lung Adenocarcinoma A549 Cells by Inhibiting Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Plasma Membrane Localization.

Technology In Cancer Research & Treatment
Li, Hui H; Ma, Ningxia N; Wang, Jing J; Wang, Ying Y; Yuan, Chao C; Wu, Jing J; Luo, Meihui M; Yang, Jiali J; Chen, Juan J; Shi, Juan J; Liu, Xiaoming X
Publication Date: 2018-01-01

Variant appearance in text: rs10487372
PubMed Link: 30384810
Variant Present in the following documents:
  • Main text
  • 10.1177_1533033818809984.pdf
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs10487372
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk.

Lung Cancer (Amsterdam, Netherlands)
Li, Yafei Y; Sun, Zhifu Z; Wu, Yanhong Y; Babovic-Vuksanovic, Dusica D; Li, Yan Y; Cunningham, Julie M JM; Pankratz, Vernon S VS; Yang, Ping P
Publication Date: 2010-10

Variant appearance in text: rs10487372
PubMed Link: 20116881
Variant Present in the following documents:
  • Main text
View BVdb publication page